Reduced colonic apoptosis in mice overexpressing bovine growth hormone occurs through changes in several kinase pathways

Growth Hormone and IGF Research

Volumn 19, Issue 5, 2009, Pages 432-441

  Bogazzi, Fausto ^a   Ultimieri, Federica ^a   Raggi, Francesco ^a   Russo, Dania ^a   Lombardi, Martina ^a   Cosci, Chiara ^a   Brogioni, Sandra ^a   Gasperi, Maurizio ^b   Bartalena, Luigi ^c   Martino, Enio ^a  

^a UNIVERSITY OF PISA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Acromegaly; Apoptosis; Colon; GH; Transgenic mice

Indexed keywords

CASPASE 3; CASPASE 9; CYTOCHROME C; DOXORUBICIN; GROWTH HORMONE; HORMONE RECEPTOR BLOCKING AGENT; LIPOCORTIN 5; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE; PROTEIN P42; PROTEIN P44; SYNAPTOPHYSIN;

ACROMEGALY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL STRAIN HT29; COLON; COLON MUCOSA; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIUM CELL; GENE OVEREXPRESSION; HISTOLOGY; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MOLECULAR MECHANICS; MOUSE; NICK END LABELING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TRANSGENIC MOUSE; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ACROMEGALY; ANIMALS; APOPTOSIS; CASPASE 3; CASPASE 9; CATTLE; COLON; GROWTH HORMONE; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOTRANSFERASES;

EID: 70349307309     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2009.01.002     Document Type: Article

References (49)

1. Ulshen M.H., Dowling R.H., Fuller C.R., Zimmermann E.M., and Lund P.K. Enhanced growth of small bowel in transgenic mice overexpressing bovine growth hormone. Gastroenterology 104 (1993) 973-980
2. Delehaye-Zervas M.C., Mertani H., Martini J.F., Nihoul-Feketé C., Morel G., and Postel-Vinay M.C. Expression of the growth hormone receptor gene in human digestive tissue. J. Clin. Endocrinol. Metab. 78 (1994) 1473-1480
3. Canani R.B., Bisceglia M., Bruzzese E., Mallardo G., and Guarino A. Growth hormone stimulates, through tyrosine kinase, ion transport and proliferation in human intestinal cells. J. Pediatr. Gastroenterol. Nutr. 28 (1999) 315-320
4. Miller M.E., Michaylira C.Z., Simmons J.G., et al. Suppressor of cytokine signaling-2: a growth hormone-inducible inhibitor of intestinal epithelial cell proliferation. Gastroenterology 127 (2004) 570-581
5. Ohneda K., Ulshen M.H., Fuller C.R., D'Ercole A.J., and Lund P.K. Enhanced growth of small bowel in transgenic mice expressing human insulin-like growth factor I. Gastroenterology 112 (1997) 444-454
6. Wilkins H.R., Ohneda K., Keku T.O., et al. Reduction of spontaneous and irradiation-induced apoptosis in small intestine of IGF-I transgenic mice. Am. J. Physiol. Gastrointest. Liver Physiol. 283 (2002) G457-G464
7. Leblond C.P., and Carriere R. The effect of growth hormone and thyroxine on the mitotic rate of the intestinal mucosa of the rat. Endocrinology 56 (1955) 261-266
8. Sesso A., and Valeri V. Nucleic acid patterns in the pancreas of hypophysectomized rat, after administration of growth hormone and of thyroxine. Exp Cell Res. 14 (1958) 201-203
9. Scow R.O., and Hagan S.N. Effect of testosterone propionate and growth hormone on growth and chemical composition of muscle and other tissues in hypophysectomized male rats. Endocrinology 77 (1965) 852-858
10. Schapiro H., Wruble L.D., and Britt L.G. The effect of hypophysectomy on the gastrointestinal tract. A review of the literature. Am. J. Dig. Dis. 15 (1970) 1019-1030
11. Yeh K.Y., and Moog F. Hormonal influences on the growth and enzymic differentiation of the small intestine of the hypophysectomized rat. Growth 42 (1978) 495-504
12. Domené H., Krishnamurthi K., Eshet R., et al. Growth hormone (GH) stimulates insulin-like growth factor-I (IGF-I) and IGF-I-binding protein-3, but not GH receptor gene expression in livers of juvenile rats. Endocrinology 133 (1993) 675-682
13. Edelblum K.L., Yan F., Yamaoka T., and Polk D.B. Regulation of apoptosis during homeostasis and disease in the intestinal epithelium. Inflamm. Bowel Dis. 12 (2006) 413-424
14. Prabhudeasi S.G., Rekhraj S., Roberts G., Darzi A.W., and Ziprin P. Apoptosis and chemo-resistance in colorectal cancer. J. Surg. Oncol. 96 (2007) 77-88
15. Baxter R.C. Signalling pathways involved in antiproliferative effects of IGFBP-3: a review. Mol. Pathol. 54 (2001) 145-148
16. Jenkins P.J., Khalaf S., Ogunkolade W., et al. Differential expression of IGF-binding protein-3 in normal and malignant colon and its influence on apoptosis. Endocrinol. Relat. Cancer 12 (2005) 891-901
17. Tei T.M., Kissmeyer-Nielsen P., Flyvbjerg A., and Christensen H. Growth hormone is a stimulating but not an essential factor in healing of colon. A study in GH-deficient dwarf rats. Scand. J. Surg. 95 (2006) 205-210
18. Williams K.L., Fuller C.R., Dieleman L.A., et al. Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone. Gastroenterology 120 (2001) 925-937
19. Jeay S., Sonenshein G.E., Postel-Vinay M.C., Kelly P.A., and Baixeras E. Growth hormone can act as a cutokine controlling survival and proliferation of immune cells: new insights into signaling pathways. Mol. Cell. Endocrinol. 188 (2002) 1-7
20. Kolle S., Stojkovic M., Boie G., Wolf E., and Sinowatz F. Growth hormone inhibits apoptosis in in vitro produced bovine embryos. Mol. Reprod. Dev. 61 (2002) 180-186
21. Haeffner A., Deas O., Mollereau B., et al. Growth hormone prevent human monocytic cells from Fas-mediated apoptosis by up-regulating Bcll-2 expression. Eur. J. Immunol. 29 (1999) 334-344
22. Bogazzi F., Ultimieri F., Raggi F., et al. Growth hormone inhibits apoptosis in human colonic cancer cell lines: antagonistic effects of peroxisome proliferator activated receptor-gamma ligands. Endocrinology 145 (2004) 3353-3362
23. Bogazzi F., Russo D., Raggi F., et al. Transgenic mice overexpressing growth hormone (GH) have reduced or increased cardiac apoptosis through activation of multiple GH-dependent or independent cell death. Endocrinology 149 (2008) 5758-5769
24. Bohlooly-Y M., Carlson L., Olsson B., et al. Vascular function and blood pressure in GH transgenic mice. Endocrinology 142 (2001) 3317-3323
25. Fu M.L., Tornell J., Schulze W., et al. Myocardial hypertrophy in transgenic mice overexpressing the bovine growth hormone (bGH) gene. J. Intern. Med. 247 (2000) 546-552
26. Liao L., Dearth R.K., Zhou S., Britton O.L., Lee A.V., and Xu J. Liver-specific overexpression of the insulin-like growth factor-I enhances somatic growth and partially prevents the effects of growth hormone deficiency. Endocrinology 147 (2006) 3877-3988
27. Menna P., Salvatorelli E., and Minotti G. Doxorubicin degradation in cardiomyocytes. J. Pharmacol. Exp. Ther. 322 (2007) 408-419
28. Bogazzi F., Russo D., Locci M.T., et al. Apoptosis is reduced in the colonic mucosa of patients with acromegaly. Clin. Endocrinol. (Oxf) 63 (2005) 683-688
29. Rodrigues S.P., Fathers K.E., Chan G., et al. CrkI and CrkII function as key signaling integrators for migration and invasion of cancer cells. Mol. Cancer Res. 3 (2005) 183-194
30. Nakamura H., Nemenoff R.A., Gronich J.H., and Bonventre J.V. Subcellular characteristics of phospholipase A, activity in the rat kidney. Enhanced cytosolic, mitochondrial and microsomal phospholipase A2 enzymatic activity after renal ischemia and reperfusion. J. Clin. Invest. 87 (1991) 1810-1818
31. Michaylira C.Z., Ramocki N.M., Simmons J.G., et al. Haplotype insufficiency for suppressor of cytokine signaling-2 enhances intestinal growth and promotes polyp formation in growth hormone-transgenic mice. Endocrinology 147 (2006) 1632-1641
32. Costoya J.A., Finidori J., Moutoussamy S., Seãris R., Devesa J., and Arce V.M. Activation of growth hormone receptor delivers an antiapoptotic signal: evidence for a role of Akt in this pathway. Endocrinology 140 (1999) 5937-5943
33. Baixeras E., Jeay S., Kelly P.A., and Postel-Vinay M.C. The proliferative and antiapoptotic actions of growth hormone and insulin-like growth factor-1 are mediated through distinct signaling pathways in the Pro-B Ba/F3 cell line. Endocrinology 142 (2001) 2968-2977
34. Jeay S., Sonenshein G.E., Postel-Vinay M.C., and Baixeras E. Growth hormone prevents apoptosis through activation of nuclear factor-kappaB in interleukin-3-dependent Ba/F3 cell line. Mol. Endocrinol. 14 (2000) 650-661
35. Jeay S., Sonenshein G.E., Kelly P.A., Postel-Vinay M.C., and Baixeras E. Growth hormone exerts antiapoptotic and proliferative effects through two different pathways involving nuclear factor-kappaB and phosphatidylinositol 3-kinase. Endocrinology 142 (2001) 147-156
36. Furstenberger G., Senn E., Morant R., Bolliger B., and Senn H.J. Serum levels of IGF-1 and IGFBP3 during adjuvant chemotherapy for primary breast cancer. Breast 15 (2006) 64-68
37. Kummel S., Eggemann H., Luftner D., et al. Significant changes in circulating plasma levels of IGF-1 and IGFBP3 after conventional or dose-intensified adjuvant treatment of breast cancer patients with one to three positive lymph nodes. Int. J. Biol. Markers 22 (2007) 186-193
38. Gonzalez-Juanatey Jr. J.R., Pineiro R., Iglesias M.J., et al. GH prevents apoptosis in cardiomyocytes cultured in vitro through a calcineurin-dependent mechanism. J. Endocrinol. 180 (2004) 325-335
39. Barclay J.L., Anderson S.T., Waters M.J., and Curlewis J.D. Regulation of suppressor of cytokine signalling 3 (SOCS3) by growth hormone in pro-B cells. Mol. Endocrinol. 10 (2007) 2503-2515
40. Hodge C., Liao J., Stofega M., Guan K., Carter-Su C., and Schwartz J. Growth hormone stimulates phosphorylation and activation of elk-1 and expression of c-fos, erg-1 and junB through activation of extracellular signal kinases 1 and 2. J. Biol. Chem. 273 (1998) 31327-31336
41. Mylonas P.G., Matsouka P.T., Papandoniou E.V., Vagianos C., Kalfarentzos F., and Alexandrides T.K. Growth hormone and insulin-like growth factor I protect intestinal cells from radiation induced apoptosis. Mol. Cell. Endocrinol. 160 (2000) 115-122
42. Wang X., Wang B., Wu K., Xu M., and Gong Z. Growth hormone downregulated the excessive apoptosis of ileal intestinal epithelial cells in rats during the early course of acute necrotizing pancreatitis. Pancreas 25 (2002) 205-209
43. Morante J., Vallejo-Cremades M.T., Gómez-García L., et al. Differential action of growth hormone in irradiated tumoral and nontumoral intestinal tissue. Dig. Dis. Sci. 48 (2003) 2159-2166
44. Cohen P., Clemmons D.R., and Rosenfeld R.G. Does the GH-IGF axis play a role in cancer pathogenesis?. Growth Horm. IGF Res. 10 (2000) 297-305
45. Orme S.M., McNally R.J., Cartwright R.A., and Belchetz P.E. Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J. Clin. Endocrinol. Metab. 83 (1998) 2730-2734
46. Colao A., Ferone D., Marzullo P., and Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocrinol. Rev. 25 (2004) 102-152
47. Bogazzi F., Cosci C., Sardella C., et al. Identification of acromegalic patients at risk of developing colonic adenomas. J. Clin. Endocrinol. Metab. 91 (2006) 1351-1356
48. Loeper S., and Ezzat S. Acromegaly: re-thinking the cancer risk. Rev. Endocr. Metab. Disord. 9 (2008) 41-58
49. Renehan A.G., O'Connell J., O'Halloran D., et al. Acromegaly and colorectal cancer: a comprehensive review of epidemiology, biological mechanisms, and clinical implications. Horm. Metab. Res. 35 (2003) 712-725